Analysis of patient‐specific NF1 variants leads to functional insights for Ras signaling that can impact personalized medicine
Authors:
- 25 October 2021
- journal article
- research article
- Published by Wiley in Human Mutation
- Vol. 43 (1) , 30-41
Abstract
We have created a panel of twenty-nine NF1 variant cDNAs representing missense (MS) variants, many with clinically relevant phenotypes, in-frame deletions, splice variants, and nonsense (NS) variants. We have determined the functional consequences of the variants, assessing their ability to produce mature neurofibromin and restore Ras signaling activity in NF1 null (-/-) cells. cDNAs demonstrate variant-specific differences in neurofibromin protein levels, suggesting that some variants lead to NF1 gene or protein instability or enhanced degradation. When expressed at high levels, some variant proteins are still able to repress Ras activity, indicating that the NF1 phenotype may be due to low protein abundance. In contrast, other variant proteins are incapable of repressing Ras activity, indicating that some do not functionally engage Ras and stimulate GTP-ase activity. We observed that effects on protein abundance and Ras activity can be mutually exclusive. These assays allow us to categorize variants by functional effects, may help to classify variants of unknown significance, and may have future implications for more directed therapeutics.Keywords
All Related Versions
This publication has 35 references indexed in Scilit:
- NF1 Molecular Characterization and Neurofibromatosis Type I Genotype-Phenotype Correlation: The French ExperienceHuman Mutation, 2013
- Assessment of the potential pathogenicity of missense mutations identified in the GTPase-activating protein (GAP)-related domain of the neurofibromatosis type-1 (NF1) geneHuman Mutation, 2012
- A shared molecular mechanism underlies the human rasopathies Legius syndrome and Neurofibromatosis-1Genes & Development, 2012
- Solubility survey of fragments of the neurofibromatosis type 1 protein neurofibrominProtein Expression and Purification, 2009
- An Absence of Cutaneous Neurofibromas Associated with a 3-bp Inframe Deletion in Exon 17 of the NF1 Gene (c.2970-2972 delAAT): Evidence of a Clinically Significant NF1 Genotype-Phenotype CorrelationThe American Journal of Human Genetics, 2007
- Case 13-2005New England Journal of Medicine, 2005
- The Mechanism of Ras GTPase Activation by NeurofibrominBiochemistry, 2003
- NF1 Tumor Suppressor Gene FunctionCell, 2001
- Exon 10b of the NF1 gene represented a mutational hotspot and harbors a recurrent missense mutation y489c associated with aberrant splicingGenetics in Medicine, 1999
- The Ras-RasGAP Complex: Structural Basis for GTPase Activation and Its Loss in Oncogenic Ras MutantsScience, 1997